RxDoctor Payments Data

Murray Las

Endocrinology, Diabetes & Metabolism · Denville, NJNPI 1114003928

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 537 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.

$6,420in general payments, 2019–2025

Across 537 payments — averaging $11.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Sanofi-aventis U.S. LLC$826
  • Lilly USA, LLC$430
  • Amneal Pharmaceuticals LLC$420
  • AbbVie$402
  • Amgen$372
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$6,34299%
  • Education$190%
  • Gifts$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,420 in reported general payments places this provider in the 75th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey →

Other endocrinology, diabetes & metabolism in Denville

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →